Galectin Therapeutics Inc. GALT
NASDAQ · United States · Health Technology
$3.90+0.14 (+3.72%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -0.14 | -0.09 | -55.6% | $0 | — | -0.6%$3.53→$3.51 |
| Q1 2026 | 2026-05-15 | -0.08 | -0.06 | -33.3% | — | — | -6.8%$2.35→$2.19 |
| Q4 2025 | 2026-03-31 | -0.08 | -0.10 | +20.0% | — | — | +4.3%$2.57→$2.68 |
| Q3 2025 | 2025-11-14 | -0.13 | -0.11 | -18.2% | — | — | +8.5%$5.53→$6.00 |
| Q2 2025 | 2025-08-14 | -0.12 | -0.16 | +25.0% | — | — | — |
| Q1 2025 | 2025-05-15 | -0.15 | -0.11 | -36.4% | — | — | — |
| Q4 2024 | 2025-03-31 | -0.19 | -0.16 | -18.8% | — | — | — |
| Q3 2024 | 2024-11-14 | -0.18 | -0.20 | +10.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.